Ligand Pharma (LGND) Tops Q2 EPS by 60c
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $298.50 +2.91%
EPS Growth %: -24.9%
Financial Fact:
Income (loss) before income taxes: 1.21M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -24.9%
Financial Fact:
Income (loss) before income taxes: 1.21M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Ligand Pharma (NASDAQ: LGND) reported Q2 EPS of $1.03, $0.60 better than the analyst estimate of $0.43. Revenue for the quarter came in at $57.4 million versus the consensus estimate of $37.73 million.
For earnings history and earnings-related data on Ligand Pharma (LGND) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Societe Generale SA (GLE:FP) (SCGLY) PT Raised to EUR83 at JPMorgan
- JPMorgan Downgrades Shenzhen Inovance Tech (300124:CH) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
